Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Gastric Cancer

Free Subscription Articles published in Anticancer Res Retrieve available abstracts of 73 articles: HTML format

Single Articles

March 2008
1. SAKELLARIOU S , Liakakos T, Ghiconti I, Hadjikokolis S, et al
   Immunohistochemical expression of P15 (INK4B) and SMAD4 in advanced gastric cancer.
   Anticancer Res. 2008;28.
   PubMed     Related articles    Abstract available
   
   
   
2. LI XH , Zheng HC, Wang ZG, Takahashi H, et al
   The clinicopathological and prognostic significance of MUC-1 expression in Japanese gastric carcinomas: an immunohistochemical study of tissue microarrays.
   Anticancer Res. 2008;28.
   PubMed     Related articles    Abstract available
   
   
   
3. CHAN SH , Wu CW, Li AF, Chi CW, et al
   miR-21 microRNA expression in human gastric carcinomas and its clinical association.
   Anticancer Res. 2008;28.
   PubMed     Related articles    Abstract available
   
   
   
4. FUJIMOTO D , Hirono Y, Goi T, Katayama K, et al
   Prognostic value of protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1) in gastric cancer.
   Anticancer Res. 2008;28.
   PubMed     Related articles    Abstract available
   
   
   
5. WEX T , Ebert MP, Kropf S, Dierkes J, et al
   Gene polymorphisms of the NOD-2/CARD-15 gene and the risk of gastric cancer in Germany.
   Anticancer Res. 2008;28.
   PubMed     Related articles    Abstract available
   
   
   
6. TSUJI A , Shima Y, Morita S, Uchida M, et al
   Combination chemotherapy of S-1 and low-dose twice-weekly cisplatin for advanced and recurrent gastric cancer in an outpatient setting: a retrospective study.
   Anticancer Res. 2008;28.
   PubMed     Related articles    Abstract available
   
   
   
7. HSU PI , Jwo JJ, Yang CL, Hsu PN, et al
   Association of the myeloperoxidase polymorphism with the risk of gastric cancer.
   Anticancer Res. 2008;28.
   PubMed     Related articles    Abstract available
   
   
   
8. KUNISAKI C , Makino H, Takagawa R, Oshima T, et al
   Impact of palliative gastrectomy in patients with incurable advanced gastric cancer.
   Anticancer Res. 2008;28.
   PubMed     Related articles    Abstract available
   
   
   
9. HUANG TC , Yeh KH, Cheng AL, Hsu CH, et al
   Weekly 24-hour infusional 5-fluorouracil as initial treatment for advanced gastric cancer with acute disseminated intravascular coagulation.
   Anticancer Res. 2008;28.
   PubMed     Related articles    Abstract available
   
   
   
10. NAGASHIMA N , Nakayama Y, Inoue Y, Nagata J, et al
    Prognostic significance of the local expression of interleukin-12 in patients with advanced gastric cancer.
    Anticancer Res. 2008;28.
    PubMed     Related articles    Abstract available
    
    
    
11. WOLL E , Devries A, Eisterer W, Hejna M, et al
    Chemotherapy in gastric cancer.
    Anticancer Res. 2008;28.
    PubMed     Related articles    Abstract available
    
    
    
12. MIYAGAWA K , Sakakura C, Nakashima S, Yoshikawa T, et al
    Overexpression of RegIV in peritoneal dissemination of gastric cancer and its potential as A novel marker for the detection of peritoneal micrometastasis.
    Anticancer Res. 2008;28.
    PubMed     Related articles    Abstract available
    
    
    January 2008
13. YAMASHITA K , Ooki A, Sakuramoto S, Kikuchi S, et al
    Lymph node metastasis density (ND)-factor association with malignant degree and ND40 as "non-curative factor" in gastric cancer.
    Anticancer Res. 2008;28.
    PubMed     Related articles    Abstract available
    
    
    
14. KOBAYASHI K , Shida A, Yamada H, Ishibashi Y, et al
    Frequent splicing aberration of the base excision repair gene hMYH in human gastric cancer.
    Anticancer Res. 2008;28.
    PubMed     Related articles    Abstract available
    
    
    
15. HSU PI , Lu PJ, Wang EM, Ger LP, et al
    Polymorphisms of death pathway genes FAS and FASL and risk of premalignant gastric lesions.
    Anticancer Res. 2008;28.
    PubMed     Related articles    Abstract available
    
    
    November 2007
16. NESI G , Bruno L, Saieva C, Caldini A, et al
    DNA ploidy and S-phase fraction as prognostic factors in surgically resected gastric carcinoma: a 7-year prospective study.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
17. YAMASHITA K , Sakuramoto S, Kikuchi S, Katada N, et al
    Surgical resection of stage IV gastric cancer and prognosis.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
18. KATSUBE T , Kikuchi T, Konnno S, Murayama M, et al
    Subdural hematoma associated with dural metastasis of gastric carcinoma: report of two cases.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
19. HOU L , Grillo P, Zhu ZZ, Lissowska J, et al
    COX1 and COX2 polymorphisms and gastric cancer risk in a Polish population.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
20. RUBIO CA , Petersson F, Hoog A, Jonasson JG, et al
    Further studies on serrated neoplasias of the cardia: a review and case report.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    September 2007
21. YAMAGUCHI K , Nakagawa S, Yabusaki H, Nashimoto A, et al
    Combination chemotherapy with 5-fluorouracil, cisplatin and paclitaxel for pretreated patients with advanced gastric cancer.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
22. CHANG HJ , Kim MH, Baek MK, Park JS, et al
    Triptolide inhibits tumor promoter-induced uPAR expression via blocking NF-kappaB signaling in human gastric AGS cells.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    July 2007
23. JIANG CG , Li JB, Liu FR, Wu T, et al
    Andrographolide inhibits the adhesion of gastric cancer cells to endothelial cells by blocking E-selectin expression.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
24. MONIG SP , Nolden B, Lubke T, Pohl A, et al
    Clinical significance of nm23 gene expression in gastric cancer.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
25. SKARLOS DV , Bai M, Goussia A, Samantas E, et al
    Expression of a molecular marker panel as a prognostic tool in gastric cancer patients treated postoperatively with docetaxel and irinotecan. A study of the Hellenic Cooperative Oncology Group.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
26. OHASHI N , Nakanishi H, Kodera Y, Ito S, et al
    Intraoperative quantitative detection of CEA mRNA in the peritoneal lavage of gastric cancer patients with transcription reverse-transcription concerted (TRC) method. A comparative study with real-time quantitative RT-PCR.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
27. SAI S , Ichikawa D, Tomita H, Ikoma D, et al
    Quantification of plasma cell-free DNA in patients with gastric cancer.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
28. KODERA Y , Ito S, Mochizuki Y, Fujitake S, et al
    A phase II study of weekly paclitaxel as second-line chemotherapy for advanced gastric Cancer (CCOG0302 study).
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
29. OZAKI T , Tamura K, Satoh T, Kurata T, et al
    Phase I study of combination therapy with S-1 and weekly docetaxel for advanced gastric cancer.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    March 2007
30. TANI N , Ichikawa D, Ikoma D, Tomita H, et al
    Circulating cell-free mRNA in plasma as a tumor marker for patients with primary and recurrent gastric cancer.
    Anticancer Res. 2007;27:1207-12.
    PubMed     Related articles    Abstract available
    
    
    
31. CHANG MS , Lee HS, Jung EJ, Kim CW, et al
    Role and prognostic significance of proapoptotic proteins in Epstein-Barr virus-infected gastric carcinomas.
    Anticancer Res. 2007;27:785-91.
    PubMed     Related articles    Abstract available
    
    
    January 2007
32. AKAIKE H , Kono K, Sugai H, Takahashi A, et al
    Expression of high mobility group box chromosomal protein-1 (HMGB-1) in gastric cancer.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
33. CARUSO RA , Fedele F, Zuccala V, Fracassi MG, et al
    Mast cell and eosinophil interaction in gastric carcinomas: ultrastructural observations.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
34. RHO M , Kim J, Jee CD, Lee YM, et al
    Expression of type 2 hexokinase and mitochondria-related genes in gastric carcinoma tissues and cell lines.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
35. PITUCH-NOWOROLSKA A , Kolodziejczyk P, Kulig J, Drabik G, et al
    Circulating tumour cells and survival of patients with gastric cancer.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
36. WACHOWIAK R , Kaifi JT, Schurr PG, Merkert P, et al
    Similar patterns of loss of heterozygosity in serum of adenocarcinoma of the distal oesophagus and the cardia in early diagnosis.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
37. POHLEN U , Rieger H, Kunick-Pohlen S, Berger G, et al
    Phase II study of regional chemotherapy using the hypoxic abdominal perfusion technique in advanced abdominal carcinoma. 5-FU pharmacokinetics, complications and outcome.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    November 2006
38. KAWAMURA K , Takiguchi N, Wada A, Takenobu H, et al
    Up-regulated expression of the uridine phosphorylase gene in human gastric tumors is correlated with a favorable prognosis.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
39. KIKUCHI S , Futawatari N, Sakuramoto S, Watanabe M, et al
    Pre-operative tumor assessment of patients with gastric cancer based on virtual endoscopy using multidetector-row computer tomography.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
40. SHIBAGUCHI H , Luo NX, Kuroki M, Zhao J, et al
    A fully human chimeric immune receptor for retargeting T-cells to CEA-expressing tumor cells.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
41. OHASHI K , Kiura K, Takigawa N, Mizushima T, et al
    Successful treatment of a patient with gastric and duodenal metastases from large cell carcinoma of the lung with carboplatin and gemcitabine.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    September 2006
42. ZHENG H , Takahashi H, Murai Y, Cui Z, et al
    Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
43. MAMMANO E , Belluco C, Sciro M, Mencarelli R, et al
    Epidermal growth factor receptor (EGFR): mutational and protein expression analysis in gastric cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
44. LIAKAKOS T , Troupis T, Ghiconti I, Triantafyllidis S, et al
    Immunohistochemical localization of thymidine phosphorylase in gastric cancer: is there a role of the differential expression in tumor cells and associated stromal cells?
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
45. YOSHIKAWA T , Tsuburaya A, Miyagi Y, Sekiguchi H, et al
    Up-regulation of hypoxia-inducible factor-1 alpha and VEGF mRNAs in peritoneal dissemination of patients with gastric cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
46. KOIZUMI W , Tanabe S, Higuchi K, Sasaki T, et al
    Optimal dose-finding study of bi-weekly paclitaxel in unresectable advanced or recurrent gastric cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
47. POLYZOS A , Tsavaris N, Kosmas C, Polyzos K, et al
    Subsets of patients with advanced gastric cancer responding to second-line chemotherapy with docetaxel-cisplatin.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
48. TONERI M , Mitsumoto Y, Shimabukuro M, Sunagawa T, et al
    Prognosis of patients with gastric carcinoma treated in remote island hospitals in Japan: a multivariable analysis.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
49. WATANABE M , Akiyama N, Sekine H, Mori M, et al
    Inhibition of poly (ADP-ribose) polymerase as a protective effect of nicaraven in ionizing radiation- and ara-C-induced cell death.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
50. HAKOZAKI M , Hojo H, Sato M, Tajino T, et al
    Establishment and characterization of a new cell line, FPS-1, derived from human undifferentiated pleomorphic sarcoma, overexpressing epidermal growth factor receptor and cyclooxygenase-2.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
51. NAKAYAMA Y , Matsumoto K, Inoue Y, Katsuki T, et al
    Correlation between the urinary dihydrouracil-uracil ratio and the 5-FU plasma concentration in patients treated with oral 5-FU analogs.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
52. HIRONAKA K , Yamaguchi Y, Okita R, Okawaki M, et al
    Essential requirement of toll-like receptor 4 expression on CD11c+ cells for locoregional immunotherapy of malignant ascites using a streptococcal preparation OK-432.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    July 2006
53. KASHIMA K , Nanashima A, Yasutake T, Sawai T, et al
    Decrease of telomeres and increase of interstitial telomeric sites in chromosomes of short-term cultured gastric carcinoma cells detected by fluorescence in situ hybridization.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
54. BARTSCH R , Woehrer S, Raderer M, Hejna M, et al
    Serum interleukin-6 levels in patients with gastric MALT lymphoma compared to gastric and pancreatic cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
55. BURBANO RR , Assumpcao PP, Leal MF, Calcagno DQ, et al
    C-MYC locus amplification as metastasis predictor in intestinal-type gastric adenocarcinomas: CGH study in Brazil.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    May 2006
56. NAKAMURA Y , Shimada N, Suzuki T, Imatani A, et al
    In situ androgen production in human gastric carcinoma--androgen synthesizing and metabolizing enzymes.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
57. TENG XJ , Shen ZX, Xiang JJ, Shen L, et al
    Pre- and post-operative plasma big endothelin-1 levels in patients with gastric carcinoma undergoing radical gastrectomy.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
58. ISHIGAMI S , Natsugoe S, Miyazono F, Nakajo A, et al
    HLA-G expression in gastric cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
59. IKOMA H , Ichikawa D, Koike H, Ikoma D, et al
    Correlation between serum DNA methylation and prognosis in gastric cancer patients.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
60. JIANG J , Xu N, Wu C, Deng H, et al
    Treatment of advanced gastric cancer by chemotherapy combined with autologous cytokine-induced killer cells.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
61. MORIOKA Y , Hibi K, Sakai M, Koike M, et al
    Aberrant methylation of the CHFR gene in digestive tract cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    March 2006
62. TAKAHASHI T , Saikawa Y, Yoshida M, Kitagawa Y, et al
    A pilot study of combination chemotherapy with S-1 and low-dose cisplatin for highly advanced gastric cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
63. IWASE H , Shimada M, Tsuzuki T, Okeya M, et al
    A phase I study of S-1 administration and a 24-h infusion of cisplatin plus paclitaxel in patients with advanced gastric cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
64. YOSHIDA T , Yoshikawa T, Tsuburaya A, Kobayashi O, et al
    Feasibility study of biweekly CPT-11 plus CDDP for S-1- and paclitaxel-refractory, metastatic gastric cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
65. RINO Y , Takanashi Y, Yukawa N, Saeki H, et al
    A phase I study of bi-weekly combination therapy with S-1 and docetaxel for advanced or recurrent gastric cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
66. NAKAMURA R , Saikawa Y, Kubota T, Kumagai A, et al
    Role of the MTT chemosensitivity test in the prognosis of gastric cancer patients after postoperative adjuvant chemotherapy.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
67. OJIMA H , Araki K, Kato T, Okamura K, et al
    Clinicopathological characteristics and outcome indicators of stage II gastric cancer according to the Japanese classification of gastric cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
68. OKADA K , Shimura T, Suehiro T, Mochiki E, et al
    Reduced galectin-3 expression is an indicator of unfavorable prognosis in gastric cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
69. OJIMA H , Saito K, Yamauchi H, Yamaki E, et al
    P16 protein abnormality in Epstein-Barr virus-associated gastric carcinomas.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
70. WU CW , Chen JH, Kao HL, Li AF, et al
    PTPN3 and PTPN4 tyrosine phosphatase expression in human gastric adenocarcinoma.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
71. AYA M , Yashiro M, Nishioka N, Onoda N, et al
    Carcinogenesis in the remnant stomach following distal gastrectomy with billroth II reconstruction is associated with high-level microsatellite instability.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
72. AJIKI T , Hirata K, Okazaki T, Horiuchi H, et al
    Thymidylate synthase and dihydropyrimidine dehydrogenase expressions in gallbladder cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    January 2006
73. KUNISAKI C , Akiyama H, Nomura M, Matsuda G, et al
    Clinicopathological properties of poorly-differentiated adenocarcinoma of the stomach: comparison of solid- and non-solid-types.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: